Chart-Confirmed Guillain-Barre Syndrome After 2009 H1N1 Influenza Vaccination Among the Medicare Population, 2009-2010
Authors:
- Laura L. PolakowskiLPLaura L. Polakowski
- Sukhminder K. SandhuSSSukhminder K. Sandhu
- David B. MartinDMDavid B. Martin
- Robert BallRBRobert Ball
- Thomas E. MaCurdyTMThomas E. MaCurdy
- Riley L. FranksRFRiley L. Franks
- Jonathan M. GibbsJGJonathan M. Gibbs
- Garner F. KroppGKGarner F. Kropp
- Armen AvagyanAAArmen Avagyan
- Jeffrey A. KelmanJKJeffrey A. Kelman
- Christopher M. WorrallCWChristopher M. Worrall
- Guoying SunGSGuoying Sun
Open Access
- 6 May 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 178 (6) , 962-973
Abstract
Given the increased risk of Guillain-Barré Syndrome (GBS) found with the 1976 swine influenza vaccine, both active surveillance and end-of-season analyses on chart-confirmed cases were performed across multiple US vaccine safety monitoring systems, including the Medicare system, to evaluate the association of GBS after 2009 monovalent H1N1 influenza vaccination. Medically reviewed cases consisted of H1N1-vaccinated Medicare beneficiaries who were hospitalized for GBS. These cases were then classified by using Brighton Collaboration diagnostic criteria. Thirty-one persons had Brighton level 1, 2, or 3 GBS or Fisher Syndrome, with symptom onset 1–119 days after vaccination. Self-controlled risk interval analyses estimated GBS risk within the 6-week period immediately following H1N1 vaccination compared with a later control period, with additional adjustment for seasonality. Our results showed an elevated risk of GBS with 2009 monovalent H1N1 vaccination (incidence rate ratio = 2.41, 95% confidence interval: 1.14, 5.11; attributable risk = 2.84 per million doses administered, 95% confidence interval: 0.21, 5.48). This observed risk was slightly higher than that seen with previous seasonal influenza vaccines; however, additional results that used a stricter case definition (Brighton level 1 or 2) were not statistically significant, and our ability to account for preceding respiratory/gastrointestinal illness was limited. Furthermore, the observed risk was substantially lower than that seen with the 1976 swine influenza vaccine.Keywords
This publication has 34 references indexed in Scilit:
- Population Incidence of Guillain-Barré Syndrome: A Systematic Review and Meta-AnalysisNeuroepidemiology, 2011
- Guillain–Barré Syndrome—A Classical Autoimmune Disease Triggered by Infection or VaccinationClinical Reviews in Allergy & Immunology, 2010
- Epidemiology of the Guillain-Barré syndromeCurrent Opinion in Neurology, 2001
- Guillain-Barré syndrome: an Italian multicentre case-control studyNeurological Sciences, 2000
- Pathogenesis of Guillain–Barré syndromeJournal of Neuroimmunology, 1999
- Nationwide Oral Poliovirus Vaccination Campaign and the Incidence of Guillain-Barr SyndromeAmerican Journal of Epidemiology, 1998
- Epidemiological study of Guillain-Barre syndrome in south east EnglandJournal of Neurology, Neurosurgery & Psychiatry, 1998
- Clinical and Epidemiologic Features of Guillain‐Barré SyndromeThe Journal of Infectious Diseases, 1997
- A prospective study of acute idiopathic neuropathy. II. Antecedent events.Journal of Neurology, Neurosurgery & Psychiatry, 1988
- Immunologic studies of rabies vaccination‐induced Guillain‐Barré syndromeNeurology, 1988